Early in 2004, after an initial fund raise of $500,000.00, Opus began operations.  As co-Managing Director, Mr. d'Arbeloff is responsible for working with QVC and outsource professionals to design and produce products designed to take advantage of emerging opportunities.

Opus Venture Group has established itself as a valued partner with QVC and has a number of unique product offers in the pipeline for late 2004 and early 2005.

Before starting Opus, Mr. d'Arbeloff worked with the founder of Big Idea Group (BIG) to develop and implement the business strategy for the Company. BIG is a Company that links independent inventors and product developers with companies interested in innovation (www.bigideagroup.net).  In its fourth year of operation, BIG has licensed more than twenty inventions to various companies and its annualized revenues exceed $2.0 million.  Mr. d'Arbeloff continues as the Company's Chairman of its Board.

Prior to joining Big Idea as Chairman, Mr. d'Arbeloff was founder and CEO of Retail Solutions - a start-up company that provided point of sale hardware/software systems primarily to convenience stores.  In three years, the company grew to $2.6 million with sales primarily in New England, the Southeast and the Midwest.

Mr. d'Arbeloff spent many years with Teradyne - a New York Stock Exchange company with 2003 worldwide revenues exceeding $1.3 billion.  The company designs, manufactures, markets and services electronic test systems and software used in the semiconductor, circuit board and telecommunication industries.

Over his career at Teradyne, Mr. d'Arbeloff held many positions including Vice President of Government and Investor Relations and Vice President and General Manager of the Semiconductor Test Group.

In this later role he directed two divisions that design, manufacture and market Teradyne's test products to the semiconductor industry.  He was responsible for the worldwide sales and service organizations that support the divisions.  He managed the group and had full P&L responsibility. Under his direction, the division grew from $300M to $500M in shipments ($800M in orders) and represented approximately 65% of Teradyne's total sales.

Mr. d'Arbeloff sits on other start-up companies' boards and one NASDAQ traded company, BioLase Technology where he is currently Audit Committee Chairman and a member of the Company's Executive Committee.  BioLase is a medical laser company with 2003 sales just under $50 million specializing in no-pain dentistry.  Mr. d'Arbeloff holds a BA degree from Harvard University.